Yagi, T.; Shoaib, M.; Kuschner, C.E.; Nishikimi, M.; Becker, L.B.; Lee, A.T.; Kim, J.
Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer. Cancers 2019, 11, 520.
https://doi.org/10.3390/cancers11040520
AMA Style
Yagi T, Shoaib M, Kuschner CE, Nishikimi M, Becker LB, Lee AT, Kim J.
Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer. Cancers. 2019; 11(4):520.
https://doi.org/10.3390/cancers11040520
Chicago/Turabian Style
Yagi, Tsukasa, Muhammad Shoaib, Cyrus E. Kuschner, Mitsuaki Nishikimi, Lance B. Becker, Annette T. Lee, and Junhwan Kim.
2019. "Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer" Cancers 11, no. 4: 520.
https://doi.org/10.3390/cancers11040520
APA Style
Yagi, T., Shoaib, M., Kuschner, C. E., Nishikimi, M., Becker, L. B., Lee, A. T., & Kim, J.
(2019). Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer. Cancers, 11(4), 520.
https://doi.org/10.3390/cancers11040520